Farallon Capital is a global investment firm that manages equity capital for institutions, including college endowments, charitable foundations, and pension plans, as well as for high net worth individuals. The firm employs a multi-strategy investment approach, which includes investing in public equity, fixed income, and private investment opportunities.

Farallon Capital Management, L.L.C.® is a global institutional asset management firm founded in 1986. We are headquartered in San Francisco and operate globally with offices in London, Singapore, Hong Kong, Tokyo and São Paulo.  We invest across asset classes, seeking to achieve superior risk-adjusted returns through a process of bottom-up fundamental analysis that emphasizes capital preservation.  While our investment philosophy remains consistent, its execution is flexible, allowing capital to shift among strategies, asset classes, and geographies based on prevailing opportunities.

SomaLogic

Tango Therapeutics

DarioHealth

NeoGenomics

Orchard Therapeutics

Annexon Biosciences

Arena Pharmaceuticals

Atento

AUTO1 Group

Exscientia

Pliant Therapeutics

Beam Therapeutics

Better Therapeutics

BioAtla

Caribou Biosciences

Generation Bio

Inivata

Farallon Capital Management

Farallon Capital

COM:FARALLONCAPITAL

Farallon Capital

Analysis Not Available